Pendulum is a pioneering microbiome wellness brand offering next-generation probiotics backed by rigorous clinical research and proprietary strain development. Founded by PhD scientists from institutions like Johns Hopkins and Stanford, Pendulum sets itself apart with its doctor-formulated products targeting metabolic health, gut function, and glucose control. Their flagship offerings—such as Metabolic Daily, Akkermansia, and Glucose Control—feature rare anaerobic strains, including live Akkermansia, a keystone probiotic supported by over 3,000 scientific publications. Pendulum is the only consumer brand with a medical probiotic clinically shown to improve A1C in type 2 diabetes. With manufacturing in a strict oxygen-free U.S. facility and partnerships with leading institutions like the Mayo Clinic, Pendulum delivers unmatched efficacy and innovation. For review websites and affiliate platforms, Pendulum offers high conversion potential through its science-first positioning, HSA/FSA eligibility, and strong endorsements from functional medicine experts—making it a standout in the premium probiotic and metabolic health category.
